Log in

Relevant bibliographies by topics / Yun ying guan li / Journal articles

To see the other types of publications on this topic, follow the link: Yun ying guan li.

Journal articles on the topic 'Yun ying guan li'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Yun ying guan li.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Li, Bei, Xian-Guo Guo, Tian-Guang Ren, et al. "Analysis on infestation and related ecology of chigger mites on large Chinese voles (Eothenomys miletus) in five provincial regions of Southwest China." International Journal for Parasitology: Parasites and Wildlife 19 (December 31, 2022): 169–79. https://doi.org/10.1016/j.ijppaw.2022.08.013.

Full text

Abstract:

Li, Bei, Guo, Xian-Guo, Ren, Tian-Guang, Peng, Pei-Ying, Song, Wen-Yu, Lv, Yan, Yin, Peng-Wu, Liu, Zhe, Liu, Xin-Hang, Qian, Ti-Jun (2022): Analysis on infestation and related ecology of chigger mites on large Chinese voles (Eothenomys miletus) in five provincial regions of Southwest China. International Journal for Parasitology: Parasites and Wildlife 19: 169-179, DOI: 10.1016/j.ijppaw.2022.08.013, URL: http://dx.doi.org/10.1016/j.ijppaw.2022.08.013

APA, Harvard, Vancouver, ISO, and other styles

2

Palanisamy, Krishnaveni, Sven Daboss, Fatemehsadat Rahide, Sonia Dsoke, and Christine Kranz. "In Situ Analytical Techniques: Solid Electrolyte Interface Analysis of Al Anode Materials for Al-Ion Batteries." ECS Meeting Abstracts MA2022-02, no. 1 (2022): 97. http://dx.doi.org/10.1149/ma2022-02197mtgabs.

Full text

Abstract:

Rechargeable post Li-ion batteries based on aluminum (Al) are gaining attention due to high abundance of Al, the high theoretical volumetric capacity, and high safety associated with the low flammability [1,2]. In comparison to Li-ion batteries (LiBs), where the solid-electrolyte interphase (SEI) has been studied for decades, little is known on SEI formation in dependence of the used electrolyte for Al electrodes. In this study, we present the electrochemical performance of Al foils with two different thicknesses (0.025 mm and 0.075 mm), which were used as negative electrode in Al-ion batterie

APA, Harvard, Vancouver, ISO, and other styles

3

Dai, Jia-Meng, Qi-Li Mi, Xue-Mei Li, et al. "The anti-TMV potency of the tobacco-derived fungus Aspergillus versicolor and its active alkaloids, as anti-TMV activity inhibitors." Phytochemistry 205 (January 31, 2023): 1–9. https://doi.org/10.1016/j.phytochem.2022.113485.

Full text

Abstract:

Dai, Jia-Meng, Mi, Qi-Li, Li, Xue-Mei, Gang, Du, Yang, Guang-Yu, Zhang, Jian-Duo, Wang, Jin, Li, Yin-Ke, Yang, Hai-Ying, Miao, Dong, Li, Zhen-Jie, Hu, Qiu-Fen (2023): The anti-TMV potency of the tobacco-derived fungus Aspergillus versicolor and its active alkaloids, as anti-TMV activity inhibitors. Phytochemistry (113485) 205: 1-9, DOI: 10.1016/j.phytochem.2022.113485, URL: http://dx.doi.org/10.1016/j.phytochem.2022.113485

APA, Harvard, Vancouver, ISO, and other styles

4

Wang, Changjun, Yan Lin, Yidong Zhou, et al. "Abstract P1-12-03: Antidiarrheal prophylaxis with loperamide for patients with lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive breast cancer who received adjuvant pyrotinib plus nab-paclitaxel: a randomized sub-study of PHAEDRA." Cancer Research 83, no. 5_Supplement (2023): P1–12–03—P1–12–03. http://dx.doi.org/10.1158/1538-7445.sabcs22-p1-12-03.

Full text

Abstract:

Abstract Background: Diarrhea is the most common adverse event of pan-HER tyrosine kinase inhibitors. There is no consensus on therapeutic or prophylactic strategy of pyrotinib-related diarrhea. PHAEDRA is an ongoing multicenter, single-arm, phase II trial conducted to evaluate adjuvant pyrotinib plus nab-paclitaxel for patients with low-risk HER2-positive breast cancer. Here, we reported the results from the sub-study of PHAEDRA, which investigated the effect of different prophylactic strategies with loperamide for diarrhea. Methods: In PHAEDRA, patients with N0/N1mi, HER2-positive invasive b

APA, Harvard, Vancouver, ISO, and other styles

5

Li, Yiqun, Hongnan Mo, Xiuwen Guan, et al. "Abstract P1-16-06: In real world, a high percentage of premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer receive chemotherapy as first-line treatment: A study of the National Cancer Center, China." Cancer Research 82, no. 4_Supplement (2022): P1–16–06—P1–16–06. http://dx.doi.org/10.1158/1538-7445.sabcs21-p1-16-06.

Full text

Abstract:

Abstract Background: In this study, we aimed to observe initial palliative treatment choices and clinical outcomes for premenopausal hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer patients (MBC) in the Chinese population in real life.Methods: The China National Cancer Center database was used to identify 2194 MBC patients diagnosed between 2004 to 2015. Premenopausal patients with HR+ HER2- MBC were included. Clinicopathological features, initial palliative treatment choices and survival information were extracted. First-line

APA, Harvard, Vancouver, ISO, and other styles

6

Chia, Tiongsun, Weiwei Wu, Li Li, et al. "Abstract 4249: IBI3019, a first-in-class EGFR/CDH17/CD16A tri-specific antibody, demonstrated potent efficacy against CRC and an excellent safety profile in preclinical studies." Cancer Research 85, no. 8_Supplement_1 (2025): 4249. https://doi.org/10.1158/1538-7445.am2025-4249.

Full text

Abstract:

Abstract Inhibition of EGFR signaling is clinically effective in colorectal cancer (CRC) as evidenced by the approval for Cetuximab in combination with chemotherapy or Encorafenib, a BRAF inhibitor, and the promising clinical results when combined with KRAS inhibitors, such as Adagrasib or Sotorasib. This underscores the clinical versatility of EGFR antibodies. However, these strategies are inevitably associated with high target-related toxicities, which limit the maximal potential of the drugs. Here, we designed IBI3019, a next-generation EGFR blocker that targets EGFR, CDH17 and CD16A. By ta

APA, Harvard, Vancouver, ISO, and other styles

7

Xing, Ying-Chun, Bin-Bin Lv, En-Qi Ye, et al. "Revalidation and redescription of Brachymystax tsinlingensis Li, 1966 (Salmoniformes: Salmonidae) from China." Zootaxa 3962, no. 1 (2015): 191–205. https://doi.org/10.11646/zootaxa.3962.1.12.

Full text

Abstract:

Xing, Ying-Chun, Lv, Bin-Bin, Ye, En-Qi, Fan, En-Yuan, Li, Shi-Yang, Wang, Li-Xin, Zhang, Chun- Guang, Zhao, Ya-Hui (2015): Revalidation and redescription of Brachymystax tsinlingensis Li, 1966 (Salmoniformes: Salmonidae) from China. Zootaxa 3962 (1): 191-205, DOI: 10.11646/zootaxa.3962.1.12

APA, Harvard, Vancouver, ISO, and other styles

8

Huang, Si-Yao, Yun Xiong, Ying-Chun Li, Xian-Fu Li, and Song-Yun Lang. "Notes on the genus Lethe Hübner, 1819 from Nujiang valley, Yunnan, China, with description of a new subspecies (Lepidoptera, Nymphalidae, Satyrinae)." Zootaxa 5092, no. 4 (2022): 464–72. https://doi.org/10.11646/zootaxa.5092.4.5.

Full text

Abstract:

Huang, Si-Yao, Xiong, Yun, Li, Ying-Chun, Li, Xian-Fu, Lang, Song-Yun (2022): Notes on the genus Lethe Hübner, 1819 from Nujiang valley, Yunnan, China, with description of a new subspecies (Lepidoptera, Nymphalidae, Satyrinae). Zootaxa 5092 (4): 464-472, DOI: 10.11646/zootaxa.5092.4.5

APA, Harvard, Vancouver, ISO, and other styles

9

Hu, Lu, and Jie Sun. "Clinical efficacy evaluation and safety study of Qishen Tongmai Yin I combined with moxibustion therapy on ASO: A retrospective study." Medicine 103, no. 44 (2024): e40110. http://dx.doi.org/10.1097/md.0000000000040110.

Full text

Abstract:

This study aimed to assess the therapeutic efficacy of moxibustion assisted therapy in combination with Qishen Tongmai Yin No. 1 on arteriosclerosis obliterans (ASO) patients. The impact on clinical symptoms, sign scores, foot dorsum temperature, foot dorsum artery blood flow, and overall clinical efficacy were analyzed. Sixty-three ASO patients from Beijing Xiaotangshan Hospital and Beijing Shijitan Hospital (January 2020–December 2021) were divided into 3 groups: a Qi Shen Tong Mai Yin I-only group, a moxibustion-only group, and a combined treatment group receiving both moxibustion and Qi Sh

APA, Harvard, Vancouver, ISO, and other styles

10

QI, SHUO, ZHI-TONG LYU, JIAN WANG, et al. "Erratum: SHUO QI, ZHI-TONG LYU, JIAN WANG, YUN-MING MO, ZHAO-CHI ZENG, YANG-JIN ZENG, KE-YUAN DAI, YUAN-QIU LI, L. LEE GRISMER & YING-YONG WANG (2022) Three new species of the genus Boulenophrys (Anura, Megophryidae) from southern China. Zootaxa, 5072: 401–438." Zootaxa 5115, no. 4 (2022): 600. https://doi.org/10.11646/zootaxa.5115.4.10.

Full text

Abstract:

QI, SHUO, LYU, ZHI-TONG, WANG, JIAN, MO, YUN-MING, ZENG, ZHAO-CHI, ZENG, YANG-JIN, DAI, KE-YUAN, LI, YUAN-QIU, GRISMER, L. LEE, WANG, YING-YONG (2022): Erratum: SHUO QI, ZHI-TONG LYU, JIAN WANG, YUN-MING MO, ZHAO-CHI ZENG, YANG-JIN ZENG, KE-YUAN DAI, YUAN-QIU LI, L. LEE GRISMER & YING-YONG WANG (2022) Three new species of the genus Boulenophrys (Anura, Megophryidae) from southern China. Zootaxa, 5072: 401–438. Zootaxa 5115 (4): 600-600, DOI: 10.11646/zootaxa.5115.4.10, URL: http://dx.doi.org/10.11646/zootaxa.5115.4.10

APA, Harvard, Vancouver, ISO, and other styles

11

Yang, Guang-Yu, Jia-Meng Dai, Qi-Li Mi, et al. "Cyclopiazonic acid type indole alkaloids from Nicotiana tabacum-derived fungus Aspergillus versicolor and their anti-tobacco mosaic virus activities." Phytochemistry 198 (June 30, 2022): 1–7. https://doi.org/10.1016/j.phytochem.2022.113137.

Full text

Abstract:

Yang, Guang-Yu, Dai, Jia-Meng, Mi, Qi-Li, Li, Zhen-Jie, Li, Xue-Mei, Zhang, Jian-Duo, Wang, Jin, Li, Yin-Ke, Wang, Wei-Guang, Zhou, Min, Hu, Qiu-Fen (2022): Cyclopiazonic acid type indole alkaloids from Nicotiana tabacum-derived fungus Aspergillus versicolor and their anti-tobacco mosaic virus activities. Phytochemistry (113137) 198: 1-7, DOI: 10.1016/j.phytochem.2022.113137, URL: http://dx.doi.org/10.1016/j.phytochem.2022.113137

APA, Harvard, Vancouver, ISO, and other styles

12

Li, Wenjun, Kaiyun Guan, Ozodbek Abduraimov, and Ying Feng. "Pedicularis multicolor (Orobanchaceae), a new replacement name for the Pedicularis inconspicua." Phytotaxa 437, no. 2 (2020): 118. https://doi.org/10.11646/phytotaxa.437.2.8.

Full text

Abstract:

Li, Wenjun, Guan, Kaiyun, Abduraimov, Ozodbek, Feng, Ying (2020): Pedicularis multicolor (Orobanchaceae), a new replacement name for the Pedicularis inconspicua. Phytotaxa 437 (2): 118-118, DOI: 10.11646/phytotaxa.437.2.8, URL: http://dx.doi.org/10.11646/phytotaxa.437.2.8

APA, Harvard, Vancouver, ISO, and other styles

13

Huo, Hui-Xia, Yu-Fan Gu, Zhi-Xiang Zhu, et al. "LC-MS-guided isolation of anti-inflammatory 2-(2-phenylethyl)chromone dimers from Chinese agarwood (Aquilaria sinensis)." Phytochemistry 158 (February 28, 2019): 46–55. https://doi.org/10.1016/j.phytochem.2018.11.003.

Full text

Abstract:

Huo, Hui-Xia, Gu, Yu-Fan, Zhu, Zhi-Xiang, Zhang, Yun-Feng, Chen, Xiao-Nan, Guan, Peng-Wei, Shi, She-Po, Song, Yue-Lin, Zhao, Yun-Fang, Tu, Peng-Fei, Li, Jun (2019): LC-MS-guided isolation of anti-inflammatory 2-(2-phenylethyl)chromone dimers from Chinese agarwood (Aquilaria sinensis). Phytochemistry 158: 46-55, DOI: 10.1016/j.phytochem.2018.11.003, URL: http://dx.doi.org/10.1016/j.phytochem.2018.11.003

APA, Harvard, Vancouver, ISO, and other styles

14

Luo, Jin, Qiaoyun Ren, Wenge Liu, et al. "Micropathogen community identification in ticks (Acari: Ixodidae) using third-generation sequencing." International Journal for Parasitology: Parasites and Wildlife 15 (August 31, 2021): 238–48. https://doi.org/10.1016/j.ijppaw.2021.06.003.

Full text

Abstract:

Luo, Jin, Ren, Qiaoyun, Liu, Wenge, Li, Xiangrui, Yin, Hong, Song, Mingxin, Zhao, Bo, Guan, Guiquan, Luo, Jianxun, Liu, Guangyuan (2021): Micropathogen community identification in ticks (Acari: Ixodidae) using third-generation sequencing. International Journal for Parasitology: Parasites and Wildlife 15: 238-248, DOI: 10.1016/j.ijppaw.2021.06.003, URL: http://dx.doi.org/10.1016/j.ijppaw.2021.06.003

APA, Harvard, Vancouver, ISO, and other styles

15

Li, Hong-Zhe, Kai-Yun Guan, Che-Wei Lin, and Ching-I. Peng. "Begonia qingchengshanensis (sect. Reichenheimia, Begoniaceae), a new species from Sichuan, China." Phytotaxa 349, no. 2 (2018): 197–200. https://doi.org/10.11646/phytotaxa.349.2.12.

Full text

Abstract:

Li, Hong-Zhe, Guan, Kai-Yun, Lin, Che-Wei, Peng, Ching-I (2018): Begonia qingchengshanensis (sect. Reichenheimia, Begoniaceae), a new species from Sichuan, China. Phytotaxa 349 (2): 197-200, DOI: 10.11646/phytotaxa.349.2.12, URL: http://dx.doi.org/10.11646/phytotaxa.349.2.12

APA, Harvard, Vancouver, ISO, and other styles

16

Zhang, Li-Xia, Yun-Hong Tan, Jian-Wu Li, Bin Wen, Jian-Tao Yin, and Qin-Ying Lan. "Hemiboea malipoensis, a new species of Gesneriaceae from southeastern Yunnan, China." Phytotaxa 174, no. 3 (2014): 165–72. https://doi.org/10.11646/phytotaxa.174.3.5.

Full text

Abstract:

Zhang, Li-Xia, Tan, Yun-Hong, Li, Jian-Wu, Wen, Bin, Yin, Jian-Tao, Lan, Qin-Ying (2014): Hemiboea malipoensis, a new species of Gesneriaceae from southeastern Yunnan, China. Phytotaxa 174 (3): 165-172, DOI: 10.11646/phytotaxa.174.3.5, URL: http://dx.doi.org/10.11646/phytotaxa.174.3.5

APA, Harvard, Vancouver, ISO, and other styles

17

Lam, Tommy Tsan-Yuk, Marcus Ho-Hin Shum, Hua-Chen Zhu, et al. "Identifying SARS-CoV-2related coronaviruses in Malayan pangolins." Nature 2020 (March 26, 2020): 1–15. https://doi.org/10.1038/s41586-020-2169-0.

Full text

Abstract:

Lam, Tommy Tsan-Yuk, Shum, Marcus Ho-Hin, Zhu, Hua-Chen, Tong, Yi-Gang, Ni, Xue-Bing, Liao, Yun-Shi, Wei, Wei, Cheung, William Yiu-Man, Li, Wen-Juan, Li, Lian-Feng, Leung, Gabriel M., Holmes, Edward C., Guan, Yi (2020): Identifying SARS-CoV-2related coronaviruses in Malayan pangolins. Nature 2020: 1-15, DOI: 10.1038/s41586-020-2169-0

APA, Harvard, Vancouver, ISO, and other styles

18

Zhu, Li, Li-Jie Gong, Dong-Rong Zhu, et al. "Cephalotaxine-type alkaloids from the seeds of Cephalotaxus fortunei and their cytotoxic activities." Phytochemistry 191 (November 30, 2021): 1–8. https://doi.org/10.1016/j.phytochem.2021.112903.

Full text

Abstract:

Zhu, Li, Gong, Li-Jie, Zhu, Dong-Rong, Zhu, Jiang-Min, Li, Yin, Kong, Ling-Yi, Luo, Jian-Guang (2021): Cephalotaxine-type alkaloids from the seeds of Cephalotaxus fortunei and their cytotoxic activities. Phytochemistry (112903) 191: 1-8, DOI: 10.1016/j.phytochem.2021.112903, URL: http://dx.doi.org/10.1016/j.phytochem.2021.112903

APA, Harvard, Vancouver, ISO, and other styles

19

Li, Yan-Da, Yun Hsiao, Di-Ying Huang, and Chen-Yang Cai. "New species of Vetuprostomis from mid-Cretaceous amber of northern Myanmar (Coleoptera: Tenebrionoidea: Prostomidae)." Zootaxa 5125, no. 5 (2022): 563–74. https://doi.org/10.11646/zootaxa.5125.5.6.

Full text

Abstract:

Li, Yan-Da, Hsiao, Yun, Huang, Di-Ying, Cai, Chen-Yang (2022): New species of Vetuprostomis from mid-Cretaceous amber of northern Myanmar (Coleoptera: Tenebrionoidea: Prostomidae). Zootaxa 5125 (5): 563-574, DOI: 10.11646/zootaxa.5125.5.6

APA, Harvard, Vancouver, ISO, and other styles

20

Huang, Si-Yao, Anton V. Volynkin, Yun Xiong, Ying-Chun Li, Aidas Saldaitis, and Xian-Fu Li. "Contribution to the knowledge of the genus Nephelomilta Hampson, 1900 (Lepidoptera, Erebidae, Arctiinae) from China with descriptions of two new species." Zootaxa 5351, no. 5 (2023): 534–42. https://doi.org/10.11646/zootaxa.5351.5.2.

Full text

Abstract:

Huang, Si-Yao, Volynkin, Anton V., Xiong, Yun, Li, Ying-Chun, Saldaitis, Aidas, Li, Xian-Fu (2023): Contribution to the knowledge of the genus Nephelomilta Hampson, 1900 (Lepidoptera, Erebidae, Arctiinae) from China with descriptions of two new species. Zootaxa 5351 (5): 534-542, DOI: 10.11646/zootaxa.5351.5.2, URL: http://dx.doi.org/10.11646/zootaxa.5351.5.2

APA, Harvard, Vancouver, ISO, and other styles

21

Nong, Dong-Xin, Ren-Chuan Hu, Yun-Feng Huang, and Li-Ying Yu. "Vernicia calcicola (Euphorbiaceae), a new species from limestone areas of Guangxi, China." Phytotaxa 587, no. 2 (2023): 205–10. https://doi.org/10.11646/phytotaxa.587.2.10.

Full text

Abstract:

Nong, Dong-Xin, Hu, Ren-Chuan, Huang, Yun-Feng, Yu, Li-Ying (2023): Vernicia calcicola (Euphorbiaceae), a new species from limestone areas of Guangxi, China. Phytotaxa 587 (2): 205-210, DOI: 10.11646/phytotaxa.587.2.10, URL: http://dx.doi.org/10.11646/phytotaxa.587.2.10

APA, Harvard, Vancouver, ISO, and other styles

22

Chen, Guan-Yu, Yun-Ling Ke, Wei-Ren Liang, and Hou-Feng Li. "Redescription of Formosan subterranean termite, Coptotermes formosanus (Blattodea: Rhinotermitidae), with three new synonyms from China." Acta Entomologica Musei Nationalis Pragae 60, no. 2 (2020): 599–608. https://doi.org/10.37520/aemnp.2020.041.

Full text

Abstract:

Chen, Guan-Yu, Ke, Yun-Ling, Liang, Wei-Ren, Li, Hou-Feng (2020): Redescription of Formosan subterranean termite, Coptotermes formosanus (Blattodea: Rhinotermitidae), with three new synonyms from China. Acta Entomologica Musei Nationalis Pragae (Acta. Ent. Mus. Natl. Pragae) 60 (2): 599-608, DOI: 10.37520/aemnp.2020.041, URL: http://dx.doi.org/10.37520/aemnp.2020.041

APA, Harvard, Vancouver, ISO, and other styles

23

LI, YAN-DA, YUN HSIAO, HIROYUKI YOSHITOMI, DI-YING HUANG, and CHEN-YANG CAI. "Homalenchodes, a new genus of Serropalpini from mid-Cretaceous amber of northern Myanmar (Coleoptera: Tenebrionoidea: Melandryidae)." Palaeoentomology 5, no. 3 (2022): 246–53. https://doi.org/10.11646/palaeoentomology.5.3.7.

Full text

Abstract:

LI, YAN-DA, HSIAO, YUN, YOSHITOMI, HIROYUKI, HUANG, DI-YING, CAI, CHEN-YANG (2022): Homalenchodes, a new genus of Serropalpini from mid-Cretaceous amber of northern Myanmar (Coleoptera: Tenebrionoidea: Melandryidae). Palaeoentomology 5 (3): 246-253, DOI: 10.11646/palaeoentomology.5.3.7, URL: http://dx.doi.org/10.11646/palaeoentomology.5.3.7

APA, Harvard, Vancouver, ISO, and other styles

24

Wu, Yun-He, Xiao-Long Liu, Wei Gao, et al. "Description of a new species of Bush frog (Anura: Rhacophoridae: Raorchestes) from northwestern Yunnan, China." Zootaxa 4941, no. 2 (2021): 239–58. https://doi.org/10.11646/zootaxa.4941.2.5.

Full text

Abstract:

Wu, Yun-He, Liu, Xiao-Long, Gao, Wei, Wang, Yu-Fan, Li, Ying-Chun, Zhou, Wei-Wei, Yuan, Zhi-Yong, Che, Jing (2021): Description of a new species of Bush frog (Anura: Rhacophoridae: Raorchestes) from northwestern Yunnan, China. Zootaxa 4941 (2): 239-258, DOI: 10.11646/zootaxa.4941.2.5

APA, Harvard, Vancouver, ISO, and other styles

25

Qi, Shuo, Zhi-Tong Lyu, Jian Wang, et al. "Three new species of the genus Boulenophrys (Anura, Megophryidae) from southern China." Zootaxa 5072, no. 5 (2021): 401–38. https://doi.org/10.11646/zootaxa.5072.5.1.

Full text

Abstract:

Qi, Shuo, Lyu, Zhi-Tong, Wang, Jian, Mo, Yun-Ming, Zeng, Zhao-Chi, Zeng, Yang-Jin, Dai, Ke-Yuan, Li, Yuan-Qiu, Grismer, L. Lee, Wang, Ying-Yong (2021): Three new species of the genus Boulenophrys (Anura, Megophryidae) from southern China. Zootaxa 5072 (5): 401-438, DOI: 10.11646/zootaxa.5072.5.1

APA, Harvard, Vancouver, ISO, and other styles

26

Wang, Changjun, Yidong Zhou, Yan Lin, et al. "Abstract OT1-12-03: Phase II study of pyrotinib plus nanoparticle albumin-bound (nab)-paclitaxel as adjuvant therapy for lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive early breast cancer (PHAEDRA)." Cancer Research 82, no. 4_Supplement (2022): OT1–12–03—OT1–12–03. http://dx.doi.org/10.1158/1538-7445.sabcs21-ot1-12-03.

Full text

Abstract:

Abstract Background: Nowadays, dual HER2-targeted therapy has become the mainstay for high-risk HER2-positive breast cancer. However, for low-risk resectable HER2-positive breast cancer, the optimal adjuvant regimen remains inconclusive. Mono anti-HER2 antibody combined with single-agent chemotherapy has become a recommended adjuvant regimen for N0, small HER2-positive tumors, but there is scarcity of evidence on tyrosine kinase inhibitors (TKIs) for low-risk HER2-positive breast cancer. The randomized phase III PHOEBE trial has proved the superiority of pyrotinib, a novel irreversible pan-Erb

APA, Harvard, Vancouver, ISO, and other styles

27

Wei, Wei, and Panya Roongruang. "Research on Inheritance and Development of Shandong Yun-Juan Zheng Music Art in Shenyang Conservatory of Music." Asian Journal of Arts and Culture 22, no. 1 (2022): 255091. http://dx.doi.org/10.48048/ajac.2022.255091.

Full text

Abstract:

In this article, the Shandong Yuncheng and Juancheng area tradition Zheng art the main way of art form, melody structure, performance, playing techniques and so on has carried on the simple demonstration, and famous Yun-Juan Zheng master Zhao Yuzhai's three representative works to illustrate the new development of Zheng art in the 20th century in Shandong, as a folk to professional colleges and universities teaching master of art, Mr. Zhao Yuzhai not only brought folk music into professional art colleges, but also cultivated a large number of outstanding artistic talents in Shenyang Conservato

APA, Harvard, Vancouver, ISO, and other styles

28

Jessi Suryani Setiawan, Anindini Winda Amalia, and Lim Lia Harumiaty. "Pengaruh Kombinasi Akupunktur dan Formula Bai Zi Yang Xin Tang Pada Klien Insomnia Sindrom Disharmoni Jantung dan Ginjal di Yayasan Sosial Dharma Warga Surabaya." JURNAL FISIOTERAPI DAN ILMU KESEHATAN SISTHANA 5, no. 2 (2023): 37–44. http://dx.doi.org/10.55606/jufdikes.v5i2.429.

Full text

Abstract:

Insomnia is one of the most common diseases in modern society, with its characteristics being difficulty sleeping at night or failure to maintain effective sleep after sleep. Conventional treatments for existing insomnia have undesirable effects when used for a long time. Treatment with acupuncture and herbs can be used as an alternative and complementary therapy in the treatment of insomnia. Research purposes to determine the effect of a combination of acupuncture and herbal therapy Bai Zi Yang Xin Tang on client insomnia with heart and kidney disharmony syndrome at Yayasan Dharma Warga Surab

APA, Harvard, Vancouver, ISO, and other styles

29

Alp, Hayriye. "Evaluation of anthropometric results after acupuncture and diet applications in obesity patients:an experimental-control study." Acupuncture & Electro-Therapeutics Research 45, no. 2 (2021): 97–106. http://dx.doi.org/10.3727/036012921x16112663844905.

Full text

Abstract:

Obesity is a disease defined by excessive fat storage in the body. It is an energy balance problem; the increase in body fat is caused by an imbalance between energy intake and energy expenditure. This study aimed to determinate the changes in the anthropometric measurements of patients after acupuncture treatment used in obesity treatment. The present study was a cross-sectional study conducted in 2019 in xxx University's GETAT Center). Patients aged between 18–65 years with a BMI > 25 were included in the study. The participants were divided into two groups: Group 1 (acupuncture and diet)

APA, Harvard, Vancouver, ISO, and other styles

30

Wei, Wei. "Inheritance of Shandong Zheng in Shenyang Conservatory of Music." Learning & Education 10, no. 7 (2022): 139. http://dx.doi.org/10.18282/l-e.v10i7.2980.

Full text

Abstract:

In this article, the Shandong tradition Zheng art the main way of art form, melody structure, performance, playing techniques and so on has carried on the simple demonstration, and famous Yun-Juan Zheng master Zhao Yuzhai’s representative works  to illustrate the new development of Zheng art in the 20th century in Shandong, as a folk to professional colleges and universities  teaching master of art, Mr. Zhao Yuzhai not only brought folk music into professional art colleges, but also cultivated a large number of outstanding artistic talents in Shenyang Conservatory of Music. Among t

APA, Harvard, Vancouver, ISO, and other styles

31

Fei, Huifang, Stefano Passerini, and Alberto Varzi. "Stable Ammonium-Ion Batteries in Diluted Electrolyte By Manipulation of H-Bonding Network Via Ethylene Glycol." ECS Meeting Abstracts MA2023-02, no. 4 (2023): 695. http://dx.doi.org/10.1149/ma2023-024695mtgabs.

Full text

Abstract:

Aqueous rechargeable batteries (ARB) arose considerable interest for stationary energy storage due to low cost, inherent safety, and environmental friendliness.[1] Besides aqueous lithium-ion batteries, various kinds of aqueous batteries have been proposed, utilizing relatively inexpensive charge carriers either based on metal (Na+, K+, Ca2+, Mg2+, Zn2+, Al3+, etc.) or non-metal cations (H3O+, NH4 + etc.).[2] Among non-metallic ion batteries, aqueous ammonium-ion batteries (AAIBs) distinguish themselves by working in near neutral or mild acidic environment, refraining from severe electrode cor

APA, Harvard, Vancouver, ISO, and other styles

32

Zeng, Mu-Sheng, Jie Yang, Qiao-Li Wang Wang, et al. "Abstract 6896: A pan-KRAS degrader for the treatment of KRAS-mutant cancers." Cancer Research 85, no. 8_Supplement_1 (2025): 6896. https://doi.org/10.1158/1538-7445.am2025-6896.

Full text

Abstract:

Abstract KRAS mutations are highly prevalent in a wide range of lethal cancers, and these mutant forms of KRAS play a crucial role in driving cancer progression and conferring resistance to treatment. While there have been advancements in the development of small molecules to target specific KRAS mutants, the presence of undruggable mutants and the emergence of secondary mutations continue to pose challenges in the clinical treatment of KRAS-mutant cancers. In this study, we developed a novel molecular tool called tumor-targeting KRAS degrader (TKD) that effectively targets a wide range of KRA

APA, Harvard, Vancouver, ISO, and other styles

33

Wang, Ying, Ping Feng, Tong-chao Jiang, Xin-yuan Guan, and Yun-fei Xia. "Abstract 281: The function of FGFR2+ cancer-associated fibroblasts on cancer stem cell expansion of esophageal squamous cell carcinoma." Cancer Research 84, no. 6_Supplement (2024): 281. http://dx.doi.org/10.1158/1538-7445.am2024-281.

Full text

Abstract:

Abstract Aims: FGFR2+ fibroblasts were reported to promote tumor progression, but the mechanisms remained unexplored in esophageal squamous cell carcinoma (ESCC).Methods: Multiplex immunohistochemistry (mIHC) displayed the distributions of FGFR2+ fibroblasts and cancer stem cells (CSCs). After FGFR2+ fibroblast isolation, tumor cells were stimulated with fibroblasts supernatant to assess radioresistance and CSC properties. RNA-seq analysis identified the downstream BMP5 expression.Results: In our preliminary study, the immunohistochemistry results showed that FGFR2+ fibroblasts were always rep

APA, Harvard, Vancouver, ISO, and other styles

34

Huang, Jiao, Wai Ying Tsang, Xiaona Fang, et al. "Abstract 4452: FASN inhibition overcomes immune evasion by upregulating MHC-I in hepatocellular carcinoma." Cancer Research 83, no. 7_Supplement (2023): 4452. http://dx.doi.org/10.1158/1538-7445.am2023-4452.

Full text

Abstract:

Abstract Immune evasion is one of the important factors leading to the progression of hepatocellular carcinoma(HCC). Restricted antigen presentation by decrease of MHC-I remains a huge barrier to triggering an immune attack. However, knowledge is limited on how to enhance antigen presentation of cancer cells. Here we identify that FASN inhibition by shRNA and inhibitors could boost MHC-I level on HCC cell surface. FASN deficiency also promotes antigen presentation and augments CD8+ T cell cytotoxicity. Mechanistically, FASN knock-down decreases the degradation of MHC-I in lysosomes. Moreover,

APA, Harvard, Vancouver, ISO, and other styles

35

Zheng, Naizhong, Yi Liu, Jinfeng Yuan, et al. "Abstract 5765: Illuminating the kinase activity starmap in NSCLC via tyrosine phosphoproteomics." Cancer Research 85, no. 8_Supplement_1 (2025): 5765. https://doi.org/10.1158/1538-7445.am2025-5765.

Full text

Abstract:

In lung cancer treatment, understanding kinase activity, particularly tyrosine phosphorylation, is crucial but incomplete. We studied tyrosine phosphoproteomics in 74 patients with non-small-cell lung cancer (NSCLC) using SH2-Superbinder and data-independent acquisition mass spectrometry. We identified 1,048 tyrosine phosphosites, the highest number reported in lung cancer research. We constructed a tyrosine phosphorylation starmap, enabling a novel and intuitive analysis of tumors versus normal adjacent tissues, revealing kinases driving tumor progression and metastasis. Subsequently, patient

APA, Harvard, Vancouver, ISO, and other styles

36

Xu, Chang, Kie Kyon Huang, Jia Hao Law, et al. "Abstract P28: Comprehensive Molecular Phenotyping of ARID1A-deficient Gastric Cancer Reveals Pervasive Epigenomic Reprogramming and Therapeutic Opportunities." Cancer Research 84, no. 8_Supplement (2024): P28. http://dx.doi.org/10.1158/1538-7445.fcs2023-p28.

Full text

Abstract:

Abstract Objective Gastric cancer (GC) is a leading cause of cancer mortality, with ARID1A being the second most frequently mutated driver gene in GC. We sought to decipher ARID1A-specific GC regulatory networks and examine therapeutic vulnerabilities arising from ARID1A loss. Design Genomic profiling of GC patients including a Singapore cohort (&gt;200 patients) was performed to derive mutational signatures of ARID1A inactivation across molecular subtypes. Single-cell transcriptomic profiles of ARID1A-mutated GCs were analyzed to examine tumor microenvironmental changes arising from ARID1

APA, Harvard, Vancouver, ISO, and other styles

37

Chen, Shu-Mei, Hsieng-Yun Huang, Chien-Kai Wang, Yi-Yuan Yang, Sy-Jye Leu, and Ying-Ying Li. "Abstract 152: Exploring the impact of heat shock protein 90 on the antitumor efficacy and stemness in medulloblastoma cells." Cancer Research 84, no. 6_Supplement (2024): 152. http://dx.doi.org/10.1158/1538-7445.am2024-152.

Full text

Abstract:

Abstract Background: Medulloblastoma (MB) is the most common children’s malignant brain tumor. Although MB can be treated with conventional chemotherapies, chemoresistance has been frequently developed and thereby hampers their therapeutic effectiveness. The preliminary reports of our research showed that some heat shock proteins have higher levels in MB cells. Among these heat shock proteins, HSP70 and HSP90 expressions are particularly high in MB CD133+ cancer stem cells (CSCs), which arouses our attention and interest. Numerous studies demonstrated that heat shock proteins are prominent in

APA, Harvard, Vancouver, ISO, and other styles

38

Man, Ki-Fong, Lei Zhou, Ying-Tung Lam, et al. "Abstract 5799: SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma." Cancer Research 83, no. 7_Supplement (2023): 5799. http://dx.doi.org/10.1158/1538-7445.am2023-5799.

Full text

Abstract:

Abstract Intratumor molecular heterogeneity of hepatocellular carcinoma (HCC) is partly attributed to the presence of cancer stem cells (CSCs), which we now know represents a critical root of tumor recurrence and chemotherapy resistance. CD133 is known to represent an important functional marker of liver CSCs. We have demonstrated CD133 to enrich following chemotherapy treatment, while CD133/Prom1-depletion would enhance sensitivity of HCC tumors to chemotherapy. Yet unfortunately, CD133 is not specific to HCC, but is also expressed in normal regenerating liver. Identifying critical factors ex

APA, Harvard, Vancouver, ISO, and other styles

39

Xu, Rui-Hua, Dan-Yun Ruan, Rong-Bo Lin, et al. "Abstract CT010: Phase I dose-escalation and expansion study of JS107, a claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC), as monotherapy or in combination for patients (pts) with advanced solid tumors." Cancer Research 85, no. 8_Supplement_2 (2025): CT010. https://doi.org/10.1158/1538-7445.am2025-ct010.

Full text

Abstract:

Abstract Background: JS107 is a monomethyl auristatin E conjugated, CLDN18.2 specific ADC. JS107 exhibited potent anti-tumor activities in preclinical studies with a tolerable safety profile. Here we report the safety and efficacy results of JS107 monotherapy or in combination for pts with advanced solid tumors from the first-in-human phase 1 trial (NCT05502393). Methods: In Part A of the study, pts with advanced solid tumors refractory to standard therapies were treated with JS107 at 0.15-3.5 mg/kg Q3W during dose escalation and CLDN18.2+ pts were treated with JS107 at 2.0 and 3.0 mg/kg Q3W d

APA, Harvard, Vancouver, ISO, and other styles

40

Ding, Xiao, Charng-Sheng Tsai, Mei-Hsuan Tsai, et al. "Abstract 5731: BGB-C354, a novel B7H3 ADC with high DAR stability and strong bystander effect, demonstrates robust antitumor activity in preclinical models." Cancer Research 85, no. 8_Supplement_1 (2025): 5731. https://doi.org/10.1158/1538-7445.am2025-5731.

Full text

Abstract:

Abstract B7H3 is a type I transmembrane protein belonging to the B7 immunoregulatory family. B7H3 is overexpressed on a wide range of solid tumors such as lung cancers, gastrointestinal cancers and gynecological cancers, but its expression is absent or low in normal tissues, making it an attractive target for anticancer therapies. BGB-C354 is a B7-H3-targeting antibody-drug conjugate (ADC) composed of a humanized anti-B7-H3 monoclonal antibody conjugated via a cleavable linker to a novel TOP1i payload, and the drug to antibody ratio (DAR) is approximately 8. Utilizing a stable ring-open conjug

APA, Harvard, Vancouver, ISO, and other styles

41

Subanakov, Alexey K., Evgeniy V. Kovtunets, Sampil Zh Choydonov, Sesegma G. Dorzhieva та Bair G. Bazarov. "Синтез и характеризация нового двойного бората рубидия–гольмия Rb3HoB6O12". Kondensirovannye sredy i mezhfaznye granitsy = Condensed Matter and Interphases 21, № 2 (2019): 278–86. http://dx.doi.org/10.17308/kcmf.2019.21/765.

Full text

Abstract:

Методом цитратной золь-гель технологии получен новый двойной борат рубидия–гольмия состава Rb3HoB6O12. Соединение кристаллизуется в тригональной сингонии (пр. гр. R32, a = 13.4038(7), с = 30.315(2) Å, V = 4716.76 Å3) и плавится инконгруэнтно при 818 °С. Попытки получить в однофазном состоянии Rb3HoB6O12 методом твердофазных реакций не привели к положительному результату   REFERENCES  Wu C., Yang G., Humphrey M.G., Zhang C. Recent advances in ultraviolet and deep-ultraviolet secondorder nonlinear optical crystals // Chem. Rev., 2018, v. 375, pp. 1–30. https://doi.o

APA, Harvard, Vancouver, ISO, and other styles

42

Costa Figueiredo, Marta. "Electrocatalytic Synthesis of Urea." ECS Meeting Abstracts MA2024-01, no. 39 (2024): 2331. http://dx.doi.org/10.1149/ma2024-01392331mtgabs.

Full text

Abstract:

Many industrial chemical processes involve a high-energy demand (often still derived from fossil fuels). Urea is an important chemical for the agricultural industry, which accounts for 70% of the global nitrogen-containing fertilizer usage. Currently, urea is produced by the reaction of liquid NH3 and CO2 [1] in a process known as the Haber-Meiser process. Despite its importance, this process suffers from high energy demand and CO2 emissions, mainly due to the NH3 synthesis step (Haber- Bosch process), which relies on fossil fuel resources. Making urea with electrochemical methods has recently

APA, Harvard, Vancouver, ISO, and other styles

43

Cheng, Ying, Jie Wang, Caicun Zhou, et al. "Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial." Cancer Research 82, no. 12_Supplement (2022): CT038. http://dx.doi.org/10.1158/1538-7445.am2022-ct038.

Full text

Abstract:

Abstract Introduction: Extensive-stage small cell lung cancer (ES-SCLC) is associated with limited treatment options and poor prognosis. Immunotherapy has recently showed robust clinical activity in ES-SCLC. In this double-blind, phase 3 trial, we evaluated adebrelimab (SHR-1316), a novel anti-PD-L1 antibody, in combination with standard chemotherapy (chemo) as first-line treatment for ES-SCLC. Methods: Patients naïve to systemic treatment for ES-SCLC were randomized 1:1 to receive 4-6 cycles of adebrelimab (20 mg/kg, iv, d1, q3w) or placebo with carboplatin (AUC 5, d1, q3w) plus etoposide (10

APA, Harvard, Vancouver, ISO, and other styles

44

Guan, Jian, Xiao Zhang, Weiwei Wu, et al. "Abstract LB055: IBI3001: A potentially first-in-class site-specifically conjugated B7-H3/EGFR bispecific ADC for multiple solid tumors." Cancer Research 84, no. 7_Supplement (2024): LB055. http://dx.doi.org/10.1158/1538-7445.am2024-lb055.

Full text

Abstract:

Abstract B7-H3 and EGFR are both clinically validated TAAs in solid tumors. We previously demonstrated in IBI334 (B7-H3/EGFR bsAb) study that (1) B7-H3 and EGFR are co-expressed in multiple solid tumors; (2) B7-H3-aided EGFR signaling inhibition was significantly more potent than Zalutumumab (EGFR mAb) and Amivantamab (c-met/EGFR bsAb); and (3) IBI334 has favorable safety profile in cynomolgus monkey at 120 mg/kg/week. Building on this optimized bispecific antibody, we site-specifically conjugated IBI334 with Exatecan (drug-antibody-ratio = 4) using the clinically validated SyntecanE platform.

APA, Harvard, Vancouver, ISO, and other styles

45

Lin, Chiao-Min, Hsaun-Yu Mu, Li-An Chu, et al. "Abstract 6771: Tumor-microenvironment-on-chip: an ex vivo drug screening platform enabling real-time observation of regional tumor responses during drug development and clinical treatments." Cancer Research 84, no. 6_Supplement (2024): 6771. http://dx.doi.org/10.1158/1538-7445.am2024-6771.

Full text

Abstract:

Abstract Background: Current tumor models face challenges in accurately replicating the intricate and dynamic conditions of the tumor microenvironment (TME), limiting predictions of drug efficacy in drug development and personalized treatment. Furthermore, the continuous and real-time observation of drug responses variations resulting from tumor heterogeneity poses challenges in existing models, including patient-derived organoids and animal models. To address these limitations, our study introduces a novel approach through a tumor-microenvironment-on-chip (TMoC) that combines 3D tissue cultiv

APA, Harvard, Vancouver, ISO, and other styles

46

Jakubek, Yasminka A., Ying Zhou, Adrienne Stilp, et al. "Abstract 3507: Mosaic chromosomal alterations in blood across ancestries via whole-genome sequencing." Cancer Research 83, no. 7_Supplement (2023): 3507. http://dx.doi.org/10.1158/1538-7445.am2023-3507.

Full text

Abstract:

Abstract Mosaic mutations in blood are common with increasing age and are prognostic markers for cancer, cardiovascular dysfunction and other diseases. This group of acquired mutations include megabase-scale mosaic chromosomal alterations (mCAs). These large mutations have mainly been surveyed using SNP array data from individuals of European (EA) or Japanese genetic ancestry. To gain a better understanding of mCA rates and associated risk factors in genetically diverse populations, we surveyed whole genome sequencing data from 67,390 individuals, including 20,132 individuals of African ancest

APA, Harvard, Vancouver, ISO, and other styles

47

Hart, Kevin C., Daniel Santos, Keyu Li, et al. "Abstract 1237: IGM-2644, a CD38xCD3 bispecific IgM T cell engager, shows enhanced anti-tumor activity compared to daratumumab in preclinical models of multiple myeloma." Cancer Research 84, no. 6_Supplement (2024): 1237. http://dx.doi.org/10.1158/1538-7445.am2024-1237.

Full text

Abstract:

Abstract Multiple myeloma (MM) is a hematologic malignancy characterized by the accumulation of monoclonal plasma cells in the bone marrow. CD38 is an attractive therapeutic target for MM due to its high expression on plasma cells, but it is also expressed on multiple subsets of normal immune cells. Approved therapies including anti-CD38 monoclonal antibodies such as daratumumab are available, however resistance inevitably develops, and toxicities such as reduced immune cell counts put patients at increased risk for infections. To address this and other issues associated with current therapies

APA, Harvard, Vancouver, ISO, and other styles

48

Zhu, Hengrui, Hanzi Sun, Wenqing Xu, et al. "Abstract P4-10-06: Preclinical characterization of BGB-43395, a potential best-in-class CDK4 selective inhibitor with potent pharmacodynamic and anti-tumor activity in HR+HER2- breast cancer models." Clinical Cancer Research 31, no. 12_Supplement (2025): P4–10–06—P4–10–06. https://doi.org/10.1158/1557-3265.sabcs24-p4-10-06.

Full text

Abstract:

Abstract Cyclin-dependent kinase (CDK) 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) in combination with endocrine therapies have become the standard of care for patients with metastatic hormone receptor-positive, HER2-negative breast cancer (HR+HER2- BC). However, HR+HER2- BC is primarily dependent on CDK4, while CDK6 inhibition by dual CDK4/6 inhibitors often leads to dose-limiting neutropenia, which requires treatment holidays or dose reductions, thus limiting sustained CDK4 inhibition. Therefore, BGB-43395, a CDK4 selective inhibitor, was developed to reduce neutropenia by spari

APA, Harvard, Vancouver, ISO, and other styles

49

Xue, Liyan, Jiaqi Wang, Dong Kuang, et al. "Abstract 2180: The PD-L1 protein expression in Chinese patients with advanced esophageal cancers: a multi-center retrospective study." Cancer Research 83, no. 7_Supplement (2023): 2180. http://dx.doi.org/10.1158/1538-7445.am2023-2180.

Full text

Abstract:

Abstract Introduction: Programmed cell death ligand-1 (PD-L1) is the ligand of programmed cell death-1 (PD-1), a member of the immunoglobulin gene superfamily that plays a role in programmed cell death. Accumulating evidence of anti-PD-1 therapy has showed improved survival benefit for esophageal cancer (EC) patients. PD-L1 has emerged as a crucial predictor for efficacy of immunotherapy. However, the understanding of PD-L1 as a biomarker is complicated by various immunohistochemistry platforms, PD-L1 antibodies, scoring systems, and cut-offs for immunotherapy. Although PD-L1 expression has be

APA, Harvard, Vancouver, ISO, and other styles

50

Wang, Wei (Vivian), Lingyu Guan, Man Xu, Qun Yin, Chen Dong, and Jing Li. "Abstract 341: VBC108: a first-in-class CDH17/CLDN18.2 targeted bispecific antibody drug conjugate (ADC) to overcome tumor heterogeneity of gastrointestinal cancers (GC, PADC, CRC, etc.)." Cancer Research 85, no. 8_Supplement_1 (2025): 341. https://doi.org/10.1158/1538-7445.am2025-341.

Full text

Abstract:

Abstract CLDN18.2 is a promising target for GI cancer therapy, with various modalities under clinical evaluation. However, these therapies face challenges due to the heterogeneous expression of CLDN18.2, leading to inconsistent efficacy and the need of patient stratification, as observed with Zolbetuximab, AZD0901 and IBI343. Besides, these treatments may induce drug resistance by downregulating CLDN18.2. Recently, CDH17 (Cadherin 17) has emerged as a novel target for biologics, often overexpressed in GI cancers. But in normal tissues, it remains inaccessible as it is hidden within the tight j

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!